The University of Oxford and its vaccine production partner AstraZeneca announced positive high-level results from an initial analysis of clinical trials of the experimental vaccine candidate, AZD1222.
Read More
The University of Oxford and its vaccine production partner AstraZeneca announced positive high-level results from an initial analysis of clinical trials of the experimental vaccine candidate, AZD1222.
Read More